• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Dupuytren's disease: anatomy, pathology, presentation, and treatment.

作者信息

Rayan Ghazi M

机构信息

Oklahoma University, Oklahoma City, Oklahoma, USA.

出版信息

Instr Course Lect. 2007;56:101-11.

PMID:17472297
Abstract

The disorder called Dupuytren's disease has been recognized for approximately 400 years. Its presentation, although seemingly rather constant, is actually extremely variable, depending on which structures are involved. A thorough knowledge of palmar fascial anatomy is essential to the understanding of Dupuytren's disease.

摘要

相似文献

1
Dupuytren's disease: anatomy, pathology, presentation, and treatment.
Instr Course Lect. 2007;56:101-11.
2
Palmar fascial complex anatomy and pathology in Dupuytren's disease.掌腱膜复合体在杜普伊特伦挛缩病中的解剖与病理
Hand Clin. 1999 Feb;15(1):73-86, vi-vii.
3
Clinical presentation and types of Dupuytren's disease.杜普伊特伦挛缩症的临床表现及类型。
Hand Clin. 1999 Feb;15(1):87-96, vii.
4
Dupuytren's contracture: an update of biomolecular aspects and therapeutic perspectives.杜普伊特伦挛缩症:生物分子层面及治疗前景的最新进展
J Hand Surg Br. 2005 Dec;30(6):557-62. doi: 10.1016/j.jhsb.2005.07.002. Epub 2005 Sep 15.
5
[Dupuytren's contracture of the fingers and its surgical treatment].[手指掌腱膜挛缩症及其外科治疗]
Vestn Khir Im I I Grek. 1988 Aug;141(8):49-54.
6
The isolated digital cord in Dupuytren's contracture: anatomy and clinical significance.掌腱膜挛缩症中孤立的指腱索:解剖结构与临床意义
J Hand Surg Am. 1985 Jan;10(1):118-24. doi: 10.1016/s0363-5023(85)80262-8.
7
Breaking the rules: Dupuytren's disease under Skoog's fibres.打破常规:斯科格纤维下的掌腱膜挛缩症
Hand Surg. 2013;18(2):255-6. doi: 10.1142/S0218810413720155.
8
Dupuytren's disease: an overview.杜普伊特伦挛缩症概述
Plast Reconstr Surg. 2000 Jul;106(1):125-34; quiz 135-6.
9
The surgical treatment of Dupuytren's contracture.掌腱膜挛缩症的外科治疗
J Bone Joint Surg Br. 1954 Feb;36-B(1):90-4. doi: 10.1302/0301-620X.36B1.90.
10
Phlegmonous-infection in first degree Dupuytren's disease.一度杜普伊特伦挛缩病中的蜂窝织炎感染
Arch Orthop Trauma Surg. 2009 Apr;129(4):445-8. doi: 10.1007/s00402-008-0589-7. Epub 2008 Mar 20.

引用本文的文献

1
A Simple Physical Exam Maneuver to Distinguish Trigger Digit, Dupuytren's Nodule, and Flexor Sheath Ganglion.一种简单的体格检查手法,可用于鉴别扳机指、掌腱膜挛缩结节和屈肌腱鞘囊肿。
Hand (N Y). 2023 Sep;18(6):1051-1052. doi: 10.1177/15589447221109644. Epub 2022 Sep 21.
2
Effect of nanoparticle-mediated delivery of SFRP4 siRNA for treating Dupuytren disease.纳米颗粒介导的SFRP4小干扰RNA递送用于治疗掌腱膜挛缩症的效果
Gene Ther. 2023 Feb;30(1-2):31-40. doi: 10.1038/s41434-022-00330-9. Epub 2022 Mar 28.
3
Assessment of palmar subcutaneous tissue vascularization in patients with Dupuytren's contracture.
掌腱膜挛缩症患者手掌皮下组织血管形成的评估
World J Orthop. 2018 Sep 18;9(9):130-137. doi: 10.5312/wjo.v9.i9.130.
4
Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial.抗肿瘤坏死因子疗法治疗杜普伊特伦挛缩症:一项随机剂量反应概念验证 2a 期临床试验。
EBioMedicine. 2018 Jul;33:282-288. doi: 10.1016/j.ebiom.2018.06.022. Epub 2018 Jul 6.
5
Calcium-dependent signaling in Dupuytren's disease.掌腱膜挛缩症中的钙依赖性信号传导
Hand (N Y). 2011 Jun;6(2):159-64. doi: 10.1007/s11552-010-9314-4. Epub 2010 Dec 15.
6
In vitro study of novel collagenase (XIAFLEX®) on Dupuytren's disease fibroblasts displays unique drug related properties.新型胶原酶(夏佛列®)对掌腱膜挛缩症成纤维细胞的体外研究显示出独特的药物相关特性。
PLoS One. 2012;7(2):e31430. doi: 10.1371/journal.pone.0031430. Epub 2012 Feb 24.
7
Dupuytren's Disease: Review of the Current Literature.杜普伊特伦挛缩症:当前文献综述
Open Orthop J. 2011;5 Suppl 2:283-8. doi: 10.2174/1874325001105010283. Epub 2011 Jul 28.
8
The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease.胶原酶在治疗杜普伊特伦挛缩症中的新兴作用。
Ther Clin Risk Manag. 2010 Nov 4;6:557-72. doi: 10.2147/TCRM.S8591.